Essa Pharma Inc. | Balance Sheet

Fiscal year is October-September. All values CAD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,146.90
2,107.60
11,808.70
4,949.10
19,168.20
Total Accounts Receivable
72.30
5,137.30
20.90
36.90
384.40
Other Current Assets
69.90
2,217.10
1,338.20
1,340.80
607.70
Total Current Assets
4,289.20
9,461.90
13,167.70
6,326.70
20,160.20
Net Property, Plant & Equipment
15.80
220.80
167.90
124.90
-
Intangible Assets
404.40
379.10
336.00
296.80
283.10
Other Assets
-
-
-
264.00
260.30
Total Assets
4,709.40
10,061.80
13,671.60
7,012.50
20,703.70
ST Debt & Current Portion LT Debt
-
-
-
2,534.60
Income Tax Payable
-
-
119.80
417.60
Other Current Liabilities
2,496.80
2,790.70
4,650.80
2,052.40
Total Current Liabilities
2,496.80
2,790.70
4,770.70
5,004.60
Long-Term Debt
-
1,325.30
-
7,420.20
Other Liabilities
-
-
9,606.50
213.50
Total Liabilities
2,496.80
4,115.90
14,377.10
12,638.30
Common Equity (Total)
877.70
5,945.90
705.60
5,625.90
Total Shareholders' Equity
2,212.60
5,945.90
705.60
5,625.90
Total Equity
2,212.60
5,945.90
705.60
5,625.90
Liabilities & Shareholders' Equity
4,709.40
10,061.80
13,671.60
7,012.50
Preferred Stock (Carrying Value)
3,090.30
-
-
-

About Essa Pharma

View Profile
Address
999 West Broadway
Vancouver British Columbia V5Z 1K5
Canada
Employees -
Website http://www.essapharma.com
Updated 07/08/2019
ESSA Pharma, Inc. is a pharmaceutical company. It engages in the development of small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D.